207 related articles for article (PubMed ID: 21777201)
1. Symmetric dimethylarginine is a marker of detrimental outcome in the acute phase after ischaemic stroke: role of renal function.
Lüneburg N; von Holten RA; Töpper RF; Schwedhelm E; Maas R; Böger RH
Clin Sci (Lond); 2012 Feb; 122(3):105-11. PubMed ID: 21777201
[TBL] [Abstract][Full Text] [Related]
2. Methylarginines and mortality in patients with end stage renal disease: a prospective cohort study.
Aucella F; Maas R; Vigilante M; Tripepi G; Schwedhelm E; Margaglione M; Gesualdo L; Boeger R; Zoccali C
Atherosclerosis; 2009 Dec; 207(2):541-5. PubMed ID: 19501358
[TBL] [Abstract][Full Text] [Related]
3. Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.
Emrich IE; Zawada AM; Martens-Lobenhoffer J; Fliser D; Wagenpfeil S; Heine GH; Bode-Böger SM
Clin Res Cardiol; 2018 Mar; 107(3):201-213. PubMed ID: 29101459
[TBL] [Abstract][Full Text] [Related]
4. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
Betz B; Möller-Ehrlich K; Kress T; Kniepert J; Schwedhelm E; Böger RH; Wanner C; Sauvant C; Schneider R
Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198
[TBL] [Abstract][Full Text] [Related]
5. Asymmetric Dimethylarginine Predicts Long-Term Outcome in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Vögeli A; Ottiger M; Meier MA; Steuer C; Bernasconi L; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Lung; 2017 Dec; 195(6):717-727. PubMed ID: 28852826
[TBL] [Abstract][Full Text] [Related]
6. Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke.
Schulze F; Carter AM; Schwedhelm E; Ajjan R; Maas R; von Holten RA; Atzler D; Grant PJ; Böger RH
Atherosclerosis; 2010 Feb; 208(2):518-23. PubMed ID: 19700158
[TBL] [Abstract][Full Text] [Related]
7. Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study.
Siegerink B; Maas R; Vossen CY; Schwedhelm E; Koenig W; Böger R; Rothenbacher D; Brenner H; Breitling LP
Clin Res Cardiol; 2013 Mar; 102(3):193-202. PubMed ID: 23073705
[TBL] [Abstract][Full Text] [Related]
8. The L-arginine pathway in acute ischemic stroke and severe carotid stenosis: temporal profiles and association with biomarkers and outcome.
Molnar T; Pusch G; Papp V; Feher G; Szapary L; Biri B; Nagy L; Keki S; Illes Z
J Stroke Cerebrovasc Dis; 2014 Sep; 23(8):2206-2214. PubMed ID: 25018114
[TBL] [Abstract][Full Text] [Related]
9. High plasma dimethylarginine levels are associated with adverse clinical outcome after stroke.
Worthmann H; Chen S; Martens-Lobenhoffer J; Li N; Deb M; Tryc AB; Goldbecker A; Dong Q; Kielstein JT; Bode-Böger SM; Weissenborn K
J Atheroscler Thromb; 2011; 18(9):753-61. PubMed ID: 21566344
[TBL] [Abstract][Full Text] [Related]
10. Admission levels of asymmetric and symmetric dimethylarginine predict long-term outcome in patients with community-acquired pneumonia.
Vögeli A; Ottiger M; Meier MA; Steuer C; Bernasconi L; Kulkarni P; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Respir Res; 2017 Jan; 18(1):25. PubMed ID: 28114935
[TBL] [Abstract][Full Text] [Related]
11. The L-Arginine-asymmetric dimethylarginine ratio is an independent predictor of mortality in dilated cardiomyopathy.
Anderssohn M; Rosenberg M; Schwedhelm E; Zugck C; Lutz M; Lüneburg N; Frey N; Böger RH
J Card Fail; 2012 Dec; 18(12):904-11. PubMed ID: 23207078
[TBL] [Abstract][Full Text] [Related]
12. Symmetrical (SDMA) and asymmetrical dimethylarginine (ADMA) in sepsis: high plasma levels as combined risk markers for sepsis survival.
Winkler MS; Nierhaus A; Rösler G; Lezius S; Harlandt O; Schwedhelm E; Böger RH; Kluge S
Crit Care; 2018 Sep; 22(1):216. PubMed ID: 30231905
[TBL] [Abstract][Full Text] [Related]
13. Circulating levels of dimethylarginines, chronic kidney disease and long-term clinical outcome in non-ST-elevation myocardial infarction.
Cavalca V; Veglia F; Squellerio I; De Metrio M; Rubino M; Porro B; Moltrasio M; Tremoli E; Marenzi G
PLoS One; 2012; 7(11):e48499. PubMed ID: 23185262
[TBL] [Abstract][Full Text] [Related]
14. Increased levels of symmetric dimethyl-arginine are associated with all-cause mortality in patients with symptomatic peripheral arterial disease.
Staniszewska A; Rajagopalan S; Al-Shaheen A; Thies F; Brittenden J
J Vasc Surg; 2015 May; 61(5):1292-8. PubMed ID: 25776186
[TBL] [Abstract][Full Text] [Related]
15. Quantification of L-arginine, asymmetric dimethylarginine and symmetric dimethylarginine in human plasma: a step improvement in precision by stable isotope dilution mass spectrometry.
Martens-Lobenhoffer J; Bode-Böger SM
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Sep; 904():140-3. PubMed ID: 22884474
[TBL] [Abstract][Full Text] [Related]
16. Elevation of serum asymmetrical and symmetrical dimethylarginine in patients with advanced glaucoma.
Javadiyan S; Burdon KP; Whiting MJ; Abhary S; Straga T; Hewitt AW; Mills RA; Craig JE
Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):1923-7. PubMed ID: 22395885
[TBL] [Abstract][Full Text] [Related]
17. Correlation of the L-Arginine Pathway with Thrombo-Inflammation May Contribute to the Outcome of Acute Ischemic Stroke.
Molnar T; Pusch G; Nagy L; Keki S; Berki T; Illes Z
J Stroke Cerebrovasc Dis; 2016 Aug; 25(8):2055-60. PubMed ID: 27263035
[TBL] [Abstract][Full Text] [Related]
18. A simple and fast liquid chromatography-tandem mass spectrometry method for measurement of underivatized L-arginine, symmetric dimethylarginine, and asymmetric dimethylarginine and establishment of the reference ranges.
El-Khoury JM; Bunch DR; Reineks E; Jackson R; Steinle R; Wang S
Anal Bioanal Chem; 2012 Jan; 402(2):771-9. PubMed ID: 22124751
[TBL] [Abstract][Full Text] [Related]
19. Asymmetric and Symmetric Dimethylarginines are Markers of Delayed Cerebral Ischemia and Neurological Outcome in Patients with Subarachnoid Hemorrhage.
Appel D; Seeberger M; Schwedhelm E; Czorlich P; Goetz AE; Böger RH; Hannemann J
Neurocrit Care; 2018 Aug; 29(1):84-93. PubMed ID: 29560598
[TBL] [Abstract][Full Text] [Related]
20. Time course of asymmetric dimethylarginine and symmetric dimethylarginine levels after successful renal transplantation.
Claes KJ; Bammens B; Kuypers DR; Meijers B; Naesens M; Sprangers B; Vanrenterghem Y; Lerut E; de Loor H; Evenepoel P
Nephrol Dial Transplant; 2014 Oct; 29(10):1965-72. PubMed ID: 24957811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]